These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15058150)

  • 1. Statins for primary and secondary prevention of coronary heart disease. A scientific review.
    Carneiro AV; Costa J; Borges M
    Rev Port Cardiol; 2004 Jan; 23(1):95-122. PubMed ID: 15058150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid lowering agents. How important are they in secondary prevention of coronary heart disease?
    Colquhoun DM
    Aust Fam Physician; 2002 Jan; 31(1):25-6, 29-30. PubMed ID: 11840884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statins in secondary prevention of coronary heart disease].
    Sandhofer F
    Wien Med Wochenschr; 1999; 149(5-6):125-8. PubMed ID: 10408003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-lowering update 2001. Aggressive new goals.
    Fenske TK
    Can Fam Physician; 2001 Feb; 47():303-9. PubMed ID: 11228031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins for stroke prevention: disappointment and hope.
    Amarenco P; Tonkin AM
    Circulation; 2004 Jun; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence.
    Preiss D; Sattar N
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):815-28. PubMed ID: 19067719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention of coronary heart disease in the elderly.
    Dornbrook-Lavender KA; Pieper JA; Roth MT
    Ann Pharmacother; 2003 Nov; 37(11):1654-63. PubMed ID: 14565805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trials.
    Silberberg JS; Henry DA
    Med J Aust; 1991 Nov; 155(10):665-6, 669-70. PubMed ID: 1834922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review.
    Paulo S; Fernandes S; Vizinho R; Carneiro AV
    Rev Port Cardiol; 2004 Nov; 23(11):1461-82. PubMed ID: 15693698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [All mortality by cause of death. The challenge of coronary prevention].
    Fernández-Cruz A
    Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in primary prevention among hyperlipidemic patients.
    McPherson R
    Can J Cardiol; 1999 Apr; 15 Suppl B():16B-19B. PubMed ID: 10350678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypercholesterolemia: to treat or not to treat? That is the question].
    Ducobu J
    Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of mortality from coronary heart disease with pravastatin.
    Tonkin AM; Ryan EW
    Biomed Pharmacother; 1999 Oct; 53(9):405-8. PubMed ID: 10554675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Statins and stroke].
    Chudzik W; Kaczorowska B; Chmielewski H; Przybyła M; Gałka M
    Pol Merkur Lekarski; 2005 Oct; 19(112):591-5. PubMed ID: 16379334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in the prevention of coronary heart disease.
    Williamson DR; Pharand C
    Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of statins on stroke and cardiovascular incidence in randomized, placebo-controlled trials with clinical endpoints].
    Márk L; Katona A
    Orv Hetil; 2000 Jul; 141(27):1501-5. PubMed ID: 10943107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.